TRINITY BIOTECH PLC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $108.7M | $77.1M |
| FY2017 | — | $65.2M | $57.6M |
| FY2018 | — | $44.1M | $30.3M |
| FY2019 | — | $4.7M | $15.2M |
| FY2020 | — | $-2.2M | $27.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $108.7M | $77.1M |
| FY2017 | — | $65.2M | $57.6M |
| FY2018 | — | $44.1M | $30.3M |
| FY2019 | — | $4.7M | $15.2M |
| FY2020 | — | $-2.2M | $27.3M |